Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3262254 | 0.98 | KDM4E (0.50) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL11976483 | 0.98 | KDM4E (0.50) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL11976494 | 0.88 | KDM4E (0.43) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL17343158 | 0.88 | CYP3A4 (0.47) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL12909803 | 0.87 | CYP3A4 (0.55) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL11976499 | 0.87 | KDM4E (0.43) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL12112873 | 0.86 | MAPT (0.58) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL31400244 | 0.85 | KDM4E (0.45) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL17350140 | 0.85 | KDM4E (0.45) | KDM4EALDH1A1KMT2ANPC1RAB9A | |
| SCHEMBL11976502 | 0.85 | ABCG2 (0.41) | KDM4EALDH1A1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844086-B2 | Method for producing halogen-crosslinked iridium dimer | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-11-24 | — | — | US | disclosed |
| US-20190211041-A1 | METHOD FOR PRODUCING HALOGEN-CROSSLINKED IRIDIUM DIMER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-07-11 | — | — | US | disclosed |
| CN-108484499-A | The method that multi-substituted isoquinoline derivative is prepared by azanol and alkynes | 清华大学 | 2018-09-04 | — | — | CN | disclosed |
| US-20180022990-A1 | COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-01-25 | — | — | US | disclosed |
| US-20180022990-A1 | COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-01-25 | — | — | US | disclosed |
| EP-3235891-A1 | COMPOSITION AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Ltd. (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-2034000-B1 | Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds | DU PONT (US) | 2015-05-06 | — | — | EP | disclosed |
| EP-2492276-B1 | METAL COMPLEX, POLYMER, AND ELEMENT OBTAINED USING SAME | SUMITOMO CHEMICAL CO (JP) | 2014-10-08 | — | — | EP | disclosed |
| EP-2492276-A1 | METAL COMPLEX, POLYMER, AND ELEMENT OBTAINED USING SAME | Sumitomo Chemical Company, Limited (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20120205585-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-16 | — | — | US | disclosed |
| US-7090929-B2 | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-08-15 | — | — | US | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1705730-A | Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds | DU PONT (US) | 2005-12-07 | — | — | CN | disclosed |
| CN-1671818-A | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | DU PONT (US) | 2005-09-21 | — | — | CN | disclosed |
| EP-1554361-A1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2005-07-20 | — | — | EP | disclosed |
| EP-1442094-A2 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS HAVING RED-ORANGE OR RED EMISSION AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-08-04 | — | — | EP | disclosed |
| US-20040072018-A1 | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | LG CHEM, LTD. (KR) | 2004-04-15 | — | — | US | disclosed |
| WO-2004015025-A1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-02-19 | — | — | WO | disclosed |
| US-20030096138-A1 | Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds | LG CHEM, LTD. (KR) | 2003-05-22 | — | — | US | disclosed |
| WO-2003040256-A2 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS HAVING RED-ORANGE OR RED EMISSION AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211041-A1 | METHOD FOR PRODUCING HALOGEN-CROSSLINKED IRIDIUM DIMER | MACF1, PPIP5K2, F2 | KDM4E 3741/4885ALDH1A1 2758/4885KMT2A 3882/4885 |
| US-10844086-B2 | Method for producing halogen-crosslinked iridium dimer | CYBA, CYBB, PPIB | KDM4E 3371/4885ALDH1A1 3343/4885KMT2A 3205/4885 |
| US-20120205585-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE USING THE SAME | HDAC10, EMG1, PRMT1 | KDM4E 1254/4885ALDH1A1 3085/4885KMT2A 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.